• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:彭斯其,孙龙.慢性乙型肝炎DNA疫苗的研究现状及进展[J].药学研究,2025,44(7):711-717[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2104次   下载 788次 本文二维码信息
码上扫一扫!
慢性乙型肝炎DNA疫苗的研究现状及进展
彭斯其,孙龙
字体:加大+|默认|缩小-
(海南医科大学第一附属医院感染科,海南 海口 570102)
摘要:
慢性乙型肝炎是由乙型肝炎病毒引起的慢性传染病,发病率高。目前的抗病毒治疗以传统肌肉注射药物为主,无法彻底清除病毒,且存在药物副作用、耐药及患者需长期或终生服药等局限性。而DNA疫苗作为一种新兴的治疗策略,因能同时诱导体液及细胞免疫反应及稳定性高的潜力而备受关注,并在临床前动物模型试验中展现了较好的结果。DNA疫苗可通过联合治疗、佐剂及电穿孔技术增强质粒DNA的摄取效率,从而显著增强疗效。本文综述了当前DNA疫苗在慢性乙型肝炎治疗中的研究进展,包括其作用机制、动物模型中的临床前研究、临床试验及未来的发展方向。
关键词:  DNA疫苗  乙型肝炎病毒  免疫治疗  电穿孔
DOI:10.13506/j.cnki.jpr.2025.07.013
基金项目:国家重点研发计划项目(No.2022YFC2305001)
Research status and progress on DNA Vaccines for chronic hepatitis B
PENG Siqi,SUN Long
(Department of Infectious Diseases, The First Affiliated Hospital of Hainan Medical University, Haikou 570102, China)
Abstract:
Chronic hepatitis B (CHB) is a chronic infectious disease caused by the hepatitis B virus (HBV), with a high global prevalence. Current antiviral therapies primarily rely on traditional intramuscular injection drugs, which still face limitations such as incomplete viral clearance, drug side effects, drug resistance, and the need for long-term or lifelong medication. As an emerging therapeutic strategy, DNA vaccines have garnered significant attention due to their potential to simultaneously induce humoral and cellular immune responses and their high stability. Preclinical studies in animal models have demonstrated promising results. By combining adjuvants and electroporation techniques, the uptake efficiency of plasmid DNA can be enhanced, significantly improving therapeutic efficacy. Preliminary results from related clinical trials have also been encouraging. This review summarizes the current research progress of DNA vaccines in CHB treatment, including their mechanisms of action, preclinical studies in animal models, clinical trials, distinctions from RNA vaccines, and future development directions.
Key words:  DNA vaccines  Hepatitis B virus  Immunotherapy  Electroporation
今日访问量:2643    总访问量:55339157
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司